SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon

SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon

Abstract Background Reactivation of adult hemoglobin (HbF) is currently a dominant therapeutic approach to sickle cell disease (SCD). In this study, we have investigated among SCD patients from Cameroon, the association of HbF level and variants in the HU-inducible small guanosine triphosphate-bindi...

Full description

Bibliographic Details
Main Authors: Gift Dineo Pule, Valentina Josiane Ngo Bitoungui, Bernard Chetcha Chemegni, Andre Pascal Kengne, Ambroise Wonkam
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Research Notes
Subjects:
SAR1a promoter
Fetal hemoglobin
Sickle cell disease
Cameroon
Online Access:http://link.springer.com/article/10.1186/s13104-017-2502-3

Internet

http://link.springer.com/article/10.1186/s13104-017-2502-3

Similar Items